Sort by
Items per page

Send to

Choose Destination

Best matches for gamma-aminobutyric acid AND neuromodulators AND neurotransmission AND schizophrenia:

A review of NMDA receptors and the phencyclidine model of schizophrenia. Thornberg SA et al. Pharmacotherapy. (1996)

Biological perspectives: the role of glutamate in schizophrenia and its treatment. Steele D et al. Perspect Psychiatr Care. (2012)

Model-based parametric study of frontostriatal abnormalities in schizophrenia patients. Tanaka S et al. BMC Psychiatry. (2010)

Search results

Items: 1 to 20 of 216


Acute phencyclidine administration induces c-Fos-immunoreactivity in interneurons in cortical and subcortical regions.

Hervig ME, Thomsen MS, Kalló I, Mikkelsen JD.

Neuroscience. 2016 Oct 15;334:13-25. doi: 10.1016/j.neuroscience.2016.07.028. Epub 2016 Jul 29.


Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.

Chuhma N, Mingote S, Kalmbach A, Yetnikoff L, Rayport S.

Biol Psychiatry. 2017 Jan 1;81(1):43-51. doi: 10.1016/j.biopsych.2016.07.002. Epub 2016 Jul 12. Review.


α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit.

Townsend M, Whyment A, Walczak JS, Jeggo R, van den Top M, Flood DG, Leventhal L, Patzke H, Koenig G.

J Neurophysiol. 2016 Dec 1;116(6):2663-2675. doi: 10.1152/jn.00243.2016. Epub 2016 Sep 21.


BDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion in vivo.

Zhang W, Daly KM, Liang B, Zhang L, Li X, Li Y, Lin DT.

J Mol Cell Biol. 2017 Apr 1;9(2):117-131. doi: 10.1093/jmcb/mjw029.


Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.

McNally JM, McCarley RW.

Curr Opin Psychiatry. 2016 May;29(3):202-10. doi: 10.1097/YCO.0000000000000244. Review.


Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.

Rowland LM, Summerfelt A, Wijtenburg SA, Du X, Chiappelli JJ, Krishna N, West J, Muellerklein F, Kochunov P, Hong LE.

JAMA Psychiatry. 2016 Feb;73(2):166-74. doi: 10.1001/jamapsychiatry.2015.2680.


Imaging the "GABA shift" in schizophrenia.

Abi-Dargham A.

Am J Psychiatry. 2015 Nov 1;172(11):1062-3. doi: 10.1176/appi.ajp.2015.15081088. No abstract available.


Gamma oscillations in V1 are correlated with GABA(A) receptor density: A multi-modal MEG and Flumazenil-PET study.

Kujala J, Jung J, Bouvard S, Lecaignard F, Lothe A, Bouet R, Ciumas C, Ryvlin P, Jerbi K.

Sci Rep. 2015 Nov 17;5:16347. doi: 10.1038/srep16347.


Tonically active NMDA receptors--a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum.

Riebe I, Seth H, Culley G, Dósa Z, Radi S, Strand K, Fröjd V, Hanse E.

Eur J Neurosci. 2016 Jan;43(2):169-78. doi: 10.1111/ejn.13128. Epub 2015 Dec 28.


GABA concentration in superior temporal sulcus predicts gamma power and perception in the sound-induced flash illusion.

Balz J, Keil J, Roa Romero Y, Mekle R, Schubert F, Aydin S, Ittermann B, Gallinat J, Senkowski D.

Neuroimage. 2016 Jan 15;125:724-730. doi: 10.1016/j.neuroimage.2015.10.087. Epub 2015 Nov 4.


Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice.

Engel M, Snikeris P, Jenner A, Karl T, Huang XF, Frank E.

Int J Neuropsychopharmacol. 2015 May;18(7):pyu114.


Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1.

Yuan Q, Yang F, Xiao Y, Tan S, Husain N, Ren M, Hu Z, Martinowich K, Ng JS, Kim PJ, Han W, Nagata K, Weinberger DR, Je HS.

Biol Psychiatry. 2016 Aug 15;80(4):312-22. doi: 10.1016/j.biopsych.2015.08.019. Epub 2015 Aug 28.


In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.

Frankle WG, Cho RY, Prasad KM, Mason NS, Paris J, Himes ML, Walker C, Lewis DA, Narendran R.

Am J Psychiatry. 2015 Nov 1;172(11):1148-59. doi: 10.1176/appi.ajp.2015.14081031. Epub 2015 Jul 2.


Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.

Kimoto S, Zaki MM, Bazmi HH, Lewis DA.

JAMA Psychiatry. 2015 Aug;72(8):747-56. doi: 10.1001/jamapsychiatry.2015.0533.


Multiple actions of a D₃ dopamine receptor agonist, PD128907, on GABAergic inhibitory transmission between medium spiny neurons in mouse nucleus accumbens shell.

Kohnomi S, Konishi S.

Neurosci Lett. 2015 Jul 23;600:17-21. doi: 10.1016/j.neulet.2015.05.056. Epub 2015 May 29.


Clozapine potentiation of GABA mediated cortical inhibition in treatment resistant schizophrenia.

Kaster TS, de Jesus D, Radhu N, Farzan F, Blumberger DM, Rajji TK, Fitzgerald PB, Daskalakis ZJ.

Schizophr Res. 2015 Jul;165(2-3):157-62. doi: 10.1016/j.schres.2015.04.015. Epub 2015 May 7.


Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.

Nomura T, Oyamada Y, Fernandes HB, Remmers CL, Xu J, Meltzer HY, Contractor A.

Neuropharmacology. 2016 Jan;100:90-7. doi: 10.1016/j.neuropharm.2015.04.012. Epub 2015 Apr 30.


Application of cross-species PET imaging to assess neurotransmitter release in brain.

Finnema SJ, Scheinin M, Shahid M, Lehto J, Borroni E, Bang-Andersen B, Sallinen J, Wong E, Farde L, Halldin C, Grimwood S.

Psychopharmacology (Berl). 2015 Nov;232(21-22):4129-57. doi: 10.1007/s00213-015-3938-6. Epub 2015 Apr 30. Review.


Neurobiological background of negative symptoms.

Galderisi S, Merlotti E, Mucci A.

Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):543-58. doi: 10.1007/s00406-015-0590-4. Epub 2015 Mar 24. Review.


Supplemental Content

Loading ...
Support Center